Ardelyx reported $-37.6M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Amgen USD 2.08B 570M Mar/2026
Ardelyx USD -37.6M 37.2M Mar/2026
aTyr Pharma USD -153K 25.59M Mar/2026
Corcept Therapeutics USD -44.72M 54.62M Mar/2026
Curis USD -24.2M 43.56M Mar/2026
Sanofi EUR 2B 3.16B Mar/2026
TG Therapeutics USD 10.23M 10.13M Jun/2026
United Therapeutics USD 372.7M 54.4M Jun/2026